Literature DB >> 19740306

A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer.

S Matsumoto1, T Hara, M Nagaoka, A Mike, K Mitsuyama, T Sako, M Yamamoto, S Kado, T Takada.   

Abstract

Interleukin-6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) signals play key roles in the pathogenesis of inflammatory bowel disease (IBD). We previously described that both intact cells and a cell wall-derived polysaccharide-peptidoglycan complex (PSPG) in a strain of lactobacillus [Lactobacillus casei Shirota (LcS)] inhibited IL-6 production in lipopolysaccharide (LPS)-stimulated lamina propria mononuclear cells (LPMCs) isolated from murine IBD. Diets with LcS improve murine IBD by suppression of IL-6 synthesis in LPMCs. Moreover, LcS supplementation with fermented milk ameliorates disease activity in patients with active ulcerative colitis. Here, we focused on the specific roles of PSPG in LcS concerning their anti-inflammatory actions. PSPG derived from LcS, and no other strain of lactobacilli, inhibited IL-6 production in LPS-stimulated murine IBD LPMCs. Purified PSPG-I from LcS inhibited IL-6 synthesis in LPS-stimulated murine IBD LPMCs through the inhibition of nuclear factor-kappaB. The anti-IL-6 action of LcS PSPG was abrogated by masking with monoclonal anti-PSPG-I. Furthermore, PSPG-I-negative L. casei strains (PSPG-I-negative mutant LcS: LC(DeltaPSPG-I), L. casei ATCC 334) did not inhibit IL-6 production. Finally, we confirmed the effects of PSPG-I on LcS in the models of both IBD and colitis-associated cancer (CAC). In the IBD model, ingestion of LcS improved ileitis and inhibited activation of IL-6/STAT3 signaling, while ingestion of the LC(DeltaPSPG-I) strain did not. In the CAC model, treatment with LcS, but not the LC(DeltaPSPG-I) strain, showed tumour-suppressive effects with an inhibition of IL-6 production in the colonic mucosa. These results suggested that a specific polysaccharide component in an L. casei strain plays a crucial role in its anti-inflammatory actions in chronic intestinal inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19740306      PMCID: PMC2753921          DOI: 10.1111/j.1365-2567.2008.02942.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  45 in total

Review 1.  Current concepts of B cell modulation.

Authors:  T Matsuda; K Yamasaki; T Taga; T Hirano; T Kishimoto
Journal:  Int Rev Immunol       Date:  1989       Impact factor: 5.311

Review 2.  Inflammatory bowel disease (2)

Authors:  D K Podolsky
Journal:  N Engl J Med       Date:  1991-10-03       Impact factor: 91.245

3.  Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei.

Authors:  T Matsuzaki; Y Nagata; S Kado; K Uchida; I Kato; S Hashimoto; T Yokokura
Journal:  APMIS       Date:  1997-08       Impact factor: 3.205

4.  Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.

Authors:  R Duchmann; E Schmitt; P Knolle; K H Meyer zum Büschenfelde; M Neurath
Journal:  Eur J Immunol       Date:  1996-04       Impact factor: 5.532

5.  Induction and prevention of colonic inflammation in IL-2-deficient mice.

Authors:  R O Ehrhardt; B R Lúdvíksson; B Gray; M Neurath; W Strober
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

6.  Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice.

Authors:  I Kato; K Endo-Tanaka; T Yokokura
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

7.  Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain.

Authors:  S Matsumoto; Y Okabe; H Setoyama; K Takayama; J Ohtsuka; H Funahashi; A Imaoka; Y Okada; Y Umesaki
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

8.  Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells.

Authors:  Akemi Imaoka; Tatsuichiro Shima; Kimitoshi Kato; Shigeaki Mizuno; Toshiki Uehara; Satoshi Matsumoto; Hiromi Setoyama; Taeko Hara; Yoshinori Umesaki
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

9.  Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.

Authors:  R K Sellon; S Tonkonogy; M Schultz; L A Dieleman; W Grenther; E Balish; D M Rennick; R B Sartor
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

View more
  29 in total

1.  Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis.

Authors:  Hironori Koga; Yoshitaka Tamiya; Keiichi Mitsuyama; Masahiko Ishibashi; Satoshi Matsumoto; Akemi Imaoka; Taeko Hara; Masatoshi Nakano; Kazutoshi Ooeda; Yoshinori Umezaki; Michio Sata
Journal:  Hepatol Int       Date:  2012-11-21       Impact factor: 6.047

Review 2.  Actual concept of "probiotics": is it more functional to science or business?

Authors:  Michele Caselli; Francesca Cassol; Girolamo Calò; John Holton; Giovanni Zuliani; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

Review 3.  Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective.

Authors:  Francesca Turroni; Marco Ventura; Ludovica F Buttó; Sabrina Duranti; Paul W O'Toole; Mary O'Connell Motherway; Douwe van Sinderen
Journal:  Cell Mol Life Sci       Date:  2013-03-21       Impact factor: 9.261

Review 4.  The role of innate immune-stimulated epithelial apoptosis during gastrointestinal inflammatory diseases.

Authors:  Richard H Siggers; David J Hackam
Journal:  Cell Mol Life Sci       Date:  2011-10-11       Impact factor: 9.261

5.  Spontaneous autoimmune gastritis and hypochlorhydria are manifest in the ileitis-prone SAMP1/YitFcs mice.

Authors:  P B Ernst; L D Erickson; W M Loo; K G Scott; E B Wiznerowicz; C C Brown; F J Torres-Velez; M S Alam; S G Black; M McDuffie; S H Feldman; J L Wallace; G W McKnight; I T Padol; R H Hunt; K S Tung
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-09-15       Impact factor: 4.052

6.  Lectin microarray reveals binding profiles of Lactobacillus casei strains in a comprehensive analysis of bacterial cell wall polysaccharides.

Authors:  Emi Yasuda; Hiroaki Tateno; Jun Hirabayashi; Jun Hirabarashi; Tohru Iino; Tomoyuki Sako
Journal:  Appl Environ Microbiol       Date:  2011-05-20       Impact factor: 4.792

7.  Structure and biological activities of a hexosamine-rich cell wall polysaccharide isolated from the probiotic Lactobacillus farciminis.

Authors:  Emmanuel Maes; Irina Sadovskaya; Mathilde Lévêque; Elisabeth Elass-Rochard; Bruno Payré; Thierry Grard; Vassilia Théodorou; Yann Guérardel; Muriel Mercier-Bonin
Journal:  Glycoconj J       Date:  2019-01-12       Impact factor: 2.916

8.  Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity.

Authors:  Long Hang; Tommy Setiawan; Arthur M Blum; Joseph Urban; Korynn Stoyanoff; Seiji Arihiro; Hans-Christian Reinecker; Joel V Weinstock
Journal:  J Immunol       Date:  2010-08-11       Impact factor: 5.422

9.  Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus.

Authors:  Seth T Walk; Arthur M Blum; Sarah Ang-Sheng Ewing; Joel V Weinstock; Vincent B Young
Journal:  Inflamm Bowel Dis       Date:  2010-11       Impact factor: 5.325

10.  Alisol B 23-Acetate Ameliorates Azoxymethane/Dextran Sodium Sulfate-Induced Male Murine Colitis-Associated Colorectal Cancer via Modulating the Composition of Gut Microbiota and Improving Intestinal Barrier.

Authors:  Huai-Chang Zhu; Xiao-Kang Jia; Yong Fan; Shao-Hua Xu; Xiao-Yan Li; Ming-Qing Huang; Meng-Liu Lan; Wen Xu; Shui-Sheng Wu
Journal:  Front Cell Infect Microbiol       Date:  2021-04-29       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.